Business
CANE is the Teucrium Sugar Fund, a series of Teucrium Commodity Trust that seeks daily NAV changes tied to a benchmark of ICE No. 11 sugar futures.
CANE was a sugar-futures vehicle with a $26.5M FY2025 net loss, improved from 2024, and no normal revenue or cash-flow rows.
The read at a glance✓ Audited against SEC data
- Business mix — Sugar futures fundNote
- Revenue — No revenue rowNote
- Net income — Loss improved to $26.5MOK
- Cash flow — No FY2025 rowNote
- Insiders — 0 purchases / 0 salesNote
- Accounting — Forensic screen unavailableNote
- Structure — Futures roll vehicleWatch
Where the revenue comes from
Fiscal 2025, as Teucrium Commodity Trust reports it. History and quarterly detail are in the app.
- Teucrium Wheat Fund$5.0M
- Teucrium Corn Fund$2.2M
- Teucrium Soybean Fund$1.3M
- Teucrium Sugar Fund$514K
- Teucrium Agricultural Fund$567
Leadership changes
From Teucrium Commodity Trust's own filings, the day they're filed.
- Brian T. MacKenzie · Chief Compliance Officer · appointmenteff. 2026-05-11
- Christi Powitzky · Chief Compliance Officer · departureeff. 2026-05-08
- Christi Powitzky · Chief Compliance Officer · appointmenteff. 2026-01-01
Latest filings
- 8-K · Company announcement2026-08-31
- 8-K · Company announcement2026-08-31
- 10-Q · Quarterly report2026-08-14
- 8-K · Company announcement2026-06-23
- 8-K · Company announcement2026-05-22
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Teucrium Commodity Trust, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.